RxDoctor Payments Data

Senora Nelson, MD

General Practice · South Holland, ILNPI 1093855835

Payments from drug & device makers

$637in general payments, 2019–2025

Across 38 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$202
  • Boehringer Ingelheim$73
  • GSK$71
  • AstraZeneca$64
  • Amarin Pharma, Inc.$38
  • Pfizer$33
  • plus $155 from 8 others

What the payments were for

  • Food & beverage$61196%
  • Education$264%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$637 in reported general payments places this provider in the 75th percentile of 3,816 general practice providers in Illinois.

See all general practice providers in Illinois

Medicare billing

Part B allowed, 2024
$49,595
Medicare patients
127
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin174$180,363
EliquisApixaban134$110,140
OzempicSemaglutide53$95,670
XareltoRivaroxaban28$34,290
EntrestoSacubitril/Valsartan39$32,582
Breo ElliptaFluticasone/Vilanterol44$26,975
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$25,046
JanuviaSitagliptin Phosphate16$21,704
RybelsusSemaglutide13$19,547
TrulicityDulaglutide15$18,967
TradjentaLinagliptin19$16,057
Advair HfaFluticasone Propion/Salmeterol28$15,295
FarxigaDapagliflozin Propanediol20$14,907
Tresiba Flextouch U-200Insulin Degludec14$14,822
Synjardy XrEmpagliflozin/Metformin Hcl13$11,686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr$73$208,106206 claims
Novo NordiskOzempic, Rybelsus$202$115,21766 claims
PfizerEliquis$33$110,140134 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta, Anoro Ellipta$71$68,934105 claims
Johnson & JohnsonXarelto$31$34,29028 claims
NovartisEntresto$19$32,58239 claims
AstraZenecaFarxiga, Symbicort$64$22,13142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,816 general practice providers in Illinois.

Other general practice in South Holland

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →